Lung Cancer Trials Ask AI to find trials
RecruitingNot applicableNCT03655015
Official study title

Patient-derived Organoid Model and Circulating Tumor Cells for Treatment Response of Lung Cancer

Study summary

Create a living biobank of PDOs from Stage I-III lung cancer patients.

Ask AI to explain this study
Start here

Key things to know

Main goalNot specified

This describes the study’s primary purpose.

What is being studiedLung Tumor Resection

The study team can explain what participation involves.

Who it may be forEarly-stage or resectable

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Apr 20, 2026 · Source: ClinicalTrials.gov

Is enrollment open?Recruiting

The study is currently accepting participants.

What kind of study?Not applicable

Observational

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?The University of Texas Health Science Center at San Antonio

Study sponsor

01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
The University of Texas Health Science Center at San Antonio
Interventions being studied
Procedure: Lung Tumor Resection
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Disease setting
Early-stage or resectable→
Treatment approach
Surgery→
03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • Read, consented to and signed the IRB-approved informed consent form prior to any study related procedure.
  • Diagnosis of lung cancer or lung mass or lymphadenopathy that will either systemic treatment or tumor resection as part of standard of care
  • Any clinical stage of lung cancer
  • Adult patients ≥18 years of age
  • Able and willing to complete a questionnaire on their environmental/occupational exposures and smoking/alcohol history
Reasons someone may not be able to joinExclusion criteria

At the discretion of the treating physician, patient will not be able to fulfill the requirements of the study.

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • UT Health San Antonio, M.D. Anderson Cancer CenterSan Antonio, Texas

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Apr 20, 2026. Always confirm current availability with the study team.

View original record ↗